The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review
- PMID: 28738696
- DOI: 10.1080/14017431.2017.1355068
The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review
Abstract
Orthostatic intolerance is defined as the provocation of symptoms upon standing, commonly caused by neurogenic orthostatic hypotension (OH) and postural tachycardia syndrome (POTS), the etiology for which has not been fully uncovered yet. Many reports have described the occurrence of dysautonomia, orthostatic intolerance and POTS following febrile illness, presumably viral and post-vaccine. Furthermore, patients with dysautonomia have higher rates of autoimmune disorders such as Hashimoto thyroiditis and SLE. Recent evidence has shown the presence of adrenergic and cholinergic receptor antibodies in patients with POTS and orthostatic hypotension. In patients with cholinergic receptor antibodies, higher titers correlate with the disease severity. Few reports have shown that immunomodulation therapy resulted in significant improvement in symptoms. In this article, we review the available literature correlating autoimmunity with orthostatic intolerance syndromes. Future studies are warranted to evaluate the prevalence of such antibodies and examine different treatment modalities in this sub group of patients.
Keywords: Adrenergic antibodies; POTS; autonomic dysregulation; cholinergic antibodies.
Similar articles
-
Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment.Herzschrittmacherther Elektrophysiol. 2018 Jun;29(2):183-186. doi: 10.1007/s00399-018-0563-1. Epub 2018 Apr 25. Herzschrittmacherther Elektrophysiol. 2018. PMID: 29696346 Review. English.
-
Autoimmune basis for postural tachycardia syndrome.J Am Heart Assoc. 2014 Feb 26;3(1):e000755. doi: 10.1161/JAHA.113.000755. J Am Heart Assoc. 2014. PMID: 24572257 Free PMC article.
-
Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome.J Am Heart Assoc. 2020 Aug 4;9(15):e015989. doi: 10.1161/JAHA.120.015989. Epub 2020 Jul 30. J Am Heart Assoc. 2020. PMID: 32750291 Free PMC article.
-
Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology.Circulation. 2022 Aug 23;146(8):613-622. doi: 10.1161/CIRCULATIONAHA.122.059971. Epub 2022 Jun 29. Circulation. 2022. PMID: 35766055 Free PMC article.
-
Syndromes of orthostatic intolerance: a hidden danger.J Intern Med. 2013 Apr;273(4):322-35. doi: 10.1111/joim.12021. J Intern Med. 2013. PMID: 23216860 Review.
Cited by
-
Tolerability of COVID-19 mRNA vaccines in patients with postural tachycardia syndrome: a cross-sectional study.F1000Res. 2022 Feb 22;11:215. doi: 10.12688/f1000research.109373.1. eCollection 2022. F1000Res. 2022. PMID: 37822957 Free PMC article.
-
Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination.Front Neurol. 2023 Aug 16;14:1221518. doi: 10.3389/fneur.2023.1221518. eCollection 2023. Front Neurol. 2023. PMID: 37654428 Free PMC article. Review.
-
Pharmacological and Electroceutical Targeting of the Cholinergic Anti-Inflammatory Pathway in Autoimmune Diseases.Pharmaceuticals (Basel). 2023 Jul 31;16(8):1089. doi: 10.3390/ph16081089. Pharmaceuticals (Basel). 2023. PMID: 37631004 Free PMC article. Review.
-
COVID-19-Induced Postural Orthostatic Tachycardia Syndrome and Dysautonomia.Cureus. 2023 Jun 10;15(6):e40235. doi: 10.7759/cureus.40235. eCollection 2023 Jun. Cureus. 2023. PMID: 37435242 Free PMC article.
-
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies.Arch Microbiol Immunol. 2023;7(2):36-61. Epub 2023 May 9. Arch Microbiol Immunol. 2023. PMID: 37388279 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
